American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

These may be signs your cancer has spread to your spine or your liver, respectively. If your prostate-specific antigen (PSA) levels continue to rise despite treatment, especially if they are rising ...

Hormonal therapy, namely targeting androgen signaling, has continued to be the mainstay of treatment for advanced prostate cancer, going all the way back to the 1940s when we first started using ...

Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery Perspective ... Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After ...

Background: A 59-year-old man on exogenous androgen therapypresented with a clinically palpable prostate nodule confined to onelobe on endorectal examination. Serum prostate-specific antigen was3 ...

it’s important to know how surgery may affect your MS symptoms. While there’s no cure for multiple sclerosis (MS), treatment can help slow disease progression, reduce flares, and help manage ...

American Cancer Society. Key statistics for prostate cancer. American Cancer Society. Prostate cancer risk factors. Johns Hopkins Medicine. Prostate cancer symptoms. Chen P, Zhang W, Wang X, Zhao K, ...